Rayonier (RYAM) Q2 2026 Earnings Call Transcript

Rayonier Advanced Materials (RYAM) reported Q2 2026 net sales of $376 million, up 18% sequentially and 11% year over year. Adjusted EBITDA rose to $40 million. Loss from continuing operations was $33 million. Management reiterated full-year positive free cash flow guidance and said its strategic alternatives review will conclude in Q4 2026.

Original reporting
Published Aug 12, 2026, 2:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rayonier (RYAM) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$RYAMBullishMed
01

Why it matters

Traders can update expectations for 2026 free cash flow trajectory based on reiterated guidance, while also stress-testing downside scenarios from tariff exposure, elevated leverage, and ongoing losses in paperboard/high-yield pulp.

02

Market read

Q2 results show a strong sequential EBITDA rebound in cellulose specialties and margin expansion, but paperboard/high-yield pulp remains negative EBITDA and tariffs plus leverage keep risk elevated.

03

What to watch

The strategic alternatives review timing (Q4 2026) and the $41M Temiscaming HPC idling charges could dominate valuation more than quarterly pricing gains, especially if leverage trends worsen.

Relevance 8/10Novelty 6/10Timing: during/just after the Q2 2026 earnings call (Aug. 5, 2026)

Background

The article is a transcript of Rayonier Advanced Materials’ Q2 2026 earnings call, covering segment performance, liquidity/leverage, tariffs, and the timeline for a strategic alternatives review.

Company-level read

Ticker impact

$RYAMBullishMedium confidence
Context

Rayonier Advanced Materials reported Q2 2026 sales of $376M and reiterated full-year positive free cash flow guidance during the earnings call.

Expected impact

Near-term bias modestly positive on improved EBITDA and margin expansion, but expect volatility around tariff and strategic-review headlines.

Evidence & confidence

The call provides multiple quantified operating metrics (sales, adjusted EBITDA, segment margins) plus a reiterated FCF target, which can re-rate near-term expectations. Offsetting risks include elevated leverage, idling charges, and tariff exposure to paperboard/high-yield pulp economics.

Market effects

Tariff-driven cost and demand uncertainty for dissolving wood pulp and related cellulose inputs can affect pricing expectations across specialty pulp and paperboard supply chains.

U.S.-focused volume exposure (75% of paperboard volume sold into the U.S.) increases sensitivity to trade actions affecting Brazil and Norway imports.

Brazil and Norway tariff monitoring may influence global pulp pricing and contract renegotiation timing into late 2026.

Counterpoint

Despite improved specialty metrics, the company still shows negative adjusted free cash flow year-to-date and a loss-making paperboard segment, so the earnings beat may not translate into near-term equity rerating.

Key entities

  • Rayonier Advanced Materials Inc.

    Subject of the earnings call transcript, reporting Q2 2026 results and reiterating full-year positive free cash flow guidance.

  • Daniel Krawczyk

    CEO who discussed tariff risks, strategic review progress, and the company’s role in nitrocellulose supply.

  • Marcus Moeltner

    CFO who provided commentary including expected back-half volume improvement for Cellulose Specialties.

Related articles

$RYAMMedAI 8/10

Rayonier Advanced Materials Q3 Earnings Call Highlights

Rayonier Advanced Materials (RYAM) reported Q3 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose to $52M. High Purity Cellulose sales increased, while Paperboard & High Yield Pulp sales declined. The company is focusing on its Cellulose Specialties franchise and expects positive free cash flow for 2026, subject to certain conditions.

$RYAMMed

Rayonier Advanced Materials Inc (RYAM) Q3 2026 Earnings Call Highlights: HPC Segment

Rayonier Advanced Materials (RYAM) reported Q3 2026 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose 30% to $52M. CEO Dan Kraupchak discussed strategic plans, including optimizing production mix and pursuing longer-term customer agreements. CFO Marcus Moltner noted $4M energy credits and $2M tariff-related costs. CS volumes are expected to exit the year at ~100,000 metric tons per quarter. Liquidity stands at $143M, with positive adjusted free cash flow of $2M YTD.

$RYAMHighAI 8/10

Rayonier Advanced Materials 3Q 2026: Revenue $382.51M, Net income ($229.77M), EPS ($3.4) — 10-Q Summary

Rayonier Advanced Materials reported 3Q 2026 revenue of $382.51M, up 8.4% YoY, but net loss widened to $229.77M. EPS loss was $3.4. Sales growth was driven by higher cellulose specialties pricing and increased volumes. The company idled uneconomic operations at Temiscaming and is targeting CS-focused production growth. A strategic review is expected to complete in Q1 2027.

$RYAMMed

RYAM Reports Third Quarter 2026 Results

RAYONIER ADVANCED MATERIALS INC. (RYAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. RYAM Reports Third Quarter 2026 Results Delivers 30% sequential growth in Adjusted EBITDA Temiscaming production economically idled following U.S. tariffs • Loss from Continuing Operations of $229 million adjusted for non-cash impairments of $221 million was $8 million, a 60% seq

$RYAMHighAI 8/10

RYAM Reports Third Quarter 2026 Results

Rayonier Advanced Materials (RYAM) reported Q3 2026 results. HPC income rose to $29M with Adjusted EBITDA of $44M, while Temiscaming operations were idled. Consolidated Adjusted EBITDA was $52M, including tariff costs. The company aims to conclude its strategic review in Q1 2027. Net sales were $383M, with HPC at $313M and Paperboard & High Yield Pulp at $70M. Operating loss was $196M, including non-cash impairments. Year-to-date Adjusted Free Cash Flow was $66M.

$RYAMMed

Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another Story

Rayonier Advanced Materials (RYAM) reported Q2 net sales of $376M, up 18% QoQ and 11% YoY, with a narrowed loss of $33M. High Purity Cellulose segment saw a 21% YoY price increase, boosting operating income by 45%. However, Cellulose Specialties volume fell 23% YoY. Management maintains a 2026 outlook for positive free cash flow and targets Q4 2026 for a strategic review conclusion.